Why 5N Plus Stock Is Back in Focus After Its Utah Expansion Plan
5N Plus (TSX:VNP) put its St. George, Utah site at the center of its growth story with plans to expand the facility by about 50%, funded within existing capital spending plans.
The project is aimed squarely at advanced materials for defence, space solar, medical imaging and industrial sensing. It is also intended to reinforce critical mineral transformation supply chains across North America for customers that rely on secure sourcing.
The Utah expansion headlines arrive after a sharp reset in 5N Plus share price momentum. The stock has a 30 day share price return of 29.6%, but that follows a 23% price decline over 90 days. Meanwhile, the 3 year total shareholder return above 9x and the 5 year total shareholder return above 11x point to very strong longer term gains.
Spot similar momentum and supply chain plays by scanning our hand picked list of 33 best rare earth metal stocks .
After a sharp rebound and with 5N Plus trading at a meaningful discount to the average analyst target, but close to some intrinsic estimates, where does a fair price really sit for this Utah expansion story?
Most Popular Narrative: 26% Undervalued
Against the last close at CA$33.10, the most followed narrative anchors 5N Plus fair value at about CA$44.76 using a discounted cash flow framework built on explicit revenue and earnings assumptions.
The expansion of the long-term supply agreement with First Solar positions 5N Plus as a critical U.S.-based supplier to the leading American solar panel manufacturer, aligning with accelerating clean energy adoption and North American supply chain security. This is expected to drive sustained and step-wise increases in semiconductor compound volumes (33% in 2025-26, with another 25% lift in 2027-28) and support multi-year revenue and earnings growth, with minimal additional capital investment required.
See why 24 investors see 5N Plus as 26% undervalued .
Result: Fair Value of CA$44.76 (UNDERVALUED)
Still, the 5N Plus story can break if reliance on a few large customers tightens, or if solar and defense demand undershoots the analyst growth playbook.
Find out about the key risks to this 5N Plus narrative .
Another View: How 5N Plus Looks On Earnings Multiples
The DCF narrative paints 5N Plus as 26% undervalued around CA$44.76. The picture shifts when you look at the P/E. At 33.1x earnings, the shares trade well above the North American Chemicals industry on 21.8x and above peers on 22.4x, while the fair ratio sits at 15.8x. That wide gap points to richer expectations baked into the price. The question is whether you think the Utah expansion and long-contract exposure justify paying that much extra for each dollar of profit.
To see how this earnings multiple stacks up in more detail, including the fair ratio and how it could change over time, take a closer look at our valuation breakdown via See what the numbers say about this price — find out in our valuation breakdown.
Next Steps
If this mix of upbeat Utah expansion expectations and richer P/E multiples feels finely balanced, move quickly to test the underlying data and weigh the trade off between concentration risks and potential upside by digging into the 3 key rewards and 1 important warning sign .
Looking for more investment ideas beyond 5N Plus?
Do not stop with one ticker. Use the Simply Wall Street Screener to compare different setups, pressure test your thesis, and spot fresh ideas before the crowd.
-
Target potential mispricings by scanning a curated pool of quality companies that screens for value and strength through the 6 high quality undervalued stocks .
-
Prioritise resilience by focusing on businesses with strong finances and funding flexibility using the list of solid balance sheet and fundamentals (7 results) .
-
Hunt for under-followed opportunities with solid fundamentals through the 9 high quality undiscovered gems .
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include VNP.TO .
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
